Gland Pharma share

Trump tariff impact: Gland Pharma, Zydus, Aurobindo shares fall up to 4%; analyst views

Sep 26, 2025, 09:22 AM IST

Gland Pharma dropped 4.03 per cent to open at Rs 1,892.50. Zydus Life fell 3.54 per cent to open at Rs 990.55. Natco Pharma slipped 2.7 per cent, Aurobindo Pharma declined 2.45 per cent

Gland Pharma share price target at Rs 2,340: MOFSL sees 19% upside, retains Buy

Aug 06, 2025, 08:27 AM IST

MOFSL has increased its earnings estimates for Gland Pharma by 9% for FY26 and 3% for FY27, citing the scale-up of GLP-1 products and potential launches in the US and EU markets.

Aurobindo, Sun Pharma, other pharma stocks in focus after 90-day Trump tariff pause

Apr 10, 2025, 10:02 AM IST

Aurobindo Pharma and Gland Pharma have fallen 9 per cent each in the past one week and 22-23 per cent in 2025 so far. Glenmark Pharma is down 9 per cent for the week month period and 14 per cent year-to-date.

Trump tariff: Aurobindo Pharma, Gland, Lupin, DRL shares rally up to 7%; here's why

Apr 03, 2025, 09:46 AM IST

Gland Pharma surged 7.33 per cent to Rs 1,647.65. Aurobindo Pharma, the largest Indian generic company with US sales, soared 6.53 per cent to Rs 1,234.35. Lupin climbed 6.35 per cent Rs 2,137.

Eicher Motors, Gland Pharma among top 4 stock picks by SMC Global

Jan 06, 2025, 12:32 PM IST

SMC Global Securities said that Gland Pharma recovered sharply and once again reclaimed its 200-DEMA on daily charts, after marking a 52 week low of Rs 1,585.70 in month of October 2024.

Gland Pharma's arm Cenexi gets 10 observations from French agency ANSM

Dec 25, 2024, 03:14 PM IST

"The inspection was concluded, and the Facility received an official notification on December 24, 2024, citing 10 observations. Cenexi is committed to working closely with the ANSM to address the Observations and will provide further updates to the exchanges as they become available," Gland Pharma stated.

Gland Pharma shares zoom 13% despite 16% YoY drop in Q2 profit; here's why

Nov 05, 2024, 01:41 PM IST

Gland Pharma Q2 FY25: The generic injectable-focused company's consolidated net profit declined to Rs 163.5 crore in Q2 FY25 from Rs 194 crore in the year-ago period. Consolidated revenue, however, increased 2 per cent year-on-year (YoY) to Rs 1,405.8 crore.

Gland Pharma shares in focus amid block deal reports; check details here

Apr 09, 2024, 09:14 AM IST

The two selling entities- Nicomac Machinery and RP Advisory Services- are connected to Dr Ravi Penmetsa, who is the former promoter of Gland Pharma.

Up to 27% upside potential! Here's why Motilal Oswal is bullish on Gland Pharma stock

Apr 02, 2024, 03:26 PM IST

The stock has recovered over 100 per cent from its 52-week low of Rs 861.50

ITC, Bajaj Finance, AB Capital among 5 stocks brokerages prefer for near-term trade

Jan 08, 2024, 11:07 AM IST

Bajaj Finance retraced back towards its 200-day exponential moving average on daily charts and seen consolidating in broader range of Rs 7,000-7,700 since then.

Top stocks of the week: CG Power, LIC, Adani Wilmar, BHEL, Gland Pharma and more

Nov 25, 2023, 08:01 AM IST

On Friday, the 30-share BSE Sensex pack slipped 48 points or 0.07% to close at 65,970, while the broader NSE Nifty index moved 7 points or 0.04% down to end at 19,795.